Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
HRMY similar filings
- 11 Apr 24 Entry into a Material Definitive Agreement
- 22 Feb 24 Harmony Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates
- 8 Jan 24 Results of Operations and Financial Condition
- 7 Dec 23 Consolidated Financial Statements
- 8 Nov 23 Harmony Biosciences Appoints
- 31 Oct 23 Harmony Biosciences Reports Strong Third Quarter 2023 Financial Results
- 13 Oct 23 Harmony Biosciences Announces Topline Data from Phase 3 Intune Study Evaluating Pitolisant In Patients with Idiopathic Hypersomnia
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the registration statements No. 333-260905 on Form S-3 and Nos. 333-248243 and 333-263077 on Form S-8 of Harmony Biosciences Holdings, Inc. of our report dated March 28 2023, with respect to the consolidated financial statements of Zynerba Pharmaceuticals, Inc., appearing in this Current Report on Form 8-K/A of Harmony Biosciences Holdings, Inc.
/s/ KPMG LLP
Philadelphia, Pennsylvania
December 7, 2023